<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE328nnn/GSE328029/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Methylation profiling</omics_type><species>Homo sapiens</species><gds_type>Methylation profiling by genome tiling array</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE328029</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>MiT Fusions, TSC1–TSC2 Divergence, and Stem-like Programs Reveal Distinct Origins and Vulnerabilities in PEComa [Methylation]</name><description>Perivascular epithelioid cell neoplasms (PEComas) are ultra-rare mesenchymal tumors lacking a molecular classification to guide therapy. Here we perform comprehensive multi-omic profiling of an unselected PEComa cohort. We identify frequent MITF rearrangements involving actin gene partners (ACTA2, ACTG1 and ACTB). Anatomical stratification reveals cyclin-dependent kinase module mutations in gynecologic tumors, whereas soft tissue, gastrointestinal, and pelvic tumors lacked mTOR pathway alterations but are enriched for TFE3/MITF rearrangements. Transcriptomic analysis defines four subtypes with distinct lineage programs—melanocytic, mesenchymal, or adipogenic—as well as unique mutational patterns and clinical behaviors. Notably, an aggressive stem-like subtype enriched for TP53/RB1 mutations exhibits high proliferation, activation of embryonic and Hedgehog signaling, immune infiltration, and resistance to mTOR inhibitors, but potential responsiveness to immunotherapy. Single-nucleus RNA sequencing reveals intra-tumoral heterogeneity within this subtype, including divergent inflammatory states. Together, these findings establish a molecular classification framework and identify actionable vulnerabilities in PEComa.</description><dates><publication>2026/04/18</publication></dates><accession>GSE328029</accession><cross_references><GSM>GSM9670609</GSM><GSM>GSM9670608</GSM><GSM>GSM9670629</GSM><GSM>GSM9670607</GSM><GSM>GSM9670606</GSM><GSM>GSM9670628</GSM><GSM>GSM9670627</GSM><GSM>GSM9670605</GSM><GSM>GSM9670626</GSM><GSM>GSM9670604</GSM><GSM>GSM9670603</GSM><GSM>GSM9670625</GSM><GSM>GSM9670624</GSM><GSM>GSM9670602</GSM><GSM>GSM9670623</GSM><GSM>GSM9670601</GSM><GSM>GSM9670611</GSM><GSM>GSM9670633</GSM><GSM>GSM9670632</GSM><GSM>GSM9670610</GSM><GSM>GSM9670599</GSM><GSM>GSM9670631</GSM><GSM>GSM9670598</GSM><GSM>GSM9670597</GSM><GSM>GSM9670630</GSM><GSM>GSM9670596</GSM><GSM>GSM9670595</GSM><GSM>GSM9670594</GSM><GSM>GSM9670593</GSM><GSM>GSM9670592</GSM><GSM>GSM9670591</GSM><GSM>GSM9670590</GSM><GSM>GSM9670619</GSM><GSM>GSM9670618</GSM><GSM>GSM9670617</GSM><GSM>GSM9670616</GSM><GSM>GSM9670615</GSM><GSM>GSM9670614</GSM><GSM>GSM9670613</GSM><GSM>GSM9670612</GSM><GSM>GSM9670600</GSM><GSM>GSM9670589</GSM><GSM>GSM9670622</GSM><GSM>GSM9670588</GSM><GSM>GSM9670621</GSM><GSM>GSM9670620</GSM><GPL>21145</GPL><GSE>328029</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>